POMGNT2 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Our analysis shows that several myopathogenes associated with secondary or tertiary dystroglycanopathies (POMT1, FKTN, POGLUT1, POMK, POMGNT2, ISPD and B4GAT1) are downregulated during satellite cell activation (Fig. 4C,E) [184].